Introducing INOSITOL: Too Cheap? Too Safe? An overlooked treatment of Illness and Disease. (FAARM Functional Anti-Ageing Regenerative Medicine - The Future of Healthcare) - Softcover

Book 6 of 8: FAARM Functional Anti-Ageing Regenerative Medicine - The Future of Healthcare

Maclay MD, Dr Christopher Brian

 
9798307262023: Introducing INOSITOL: Too Cheap? Too Safe? An overlooked treatment of Illness and Disease. (FAARM Functional Anti-Ageing Regenerative Medicine - The Future of Healthcare)

Synopsis

You have probably never heard of Inositol. Why would you have? It is just a simple sugar molecule, one that your body does not break down into energy like glucose or fructose. Despite its simplicity, inositol holds incredible promise as a supplement, particularly for mental health and certain hormonal conditions.
Exceptionally safe and naturally present in many foods and the human body, inositol has been shown to have profound effects on a range of mental health conditions. But there is a catch—one that explains why you likely haven’t heard much about it.
Inositol is not patented, nor is it likely to ever be so. Without the promise of lucrative patent protection, pharmaceutical companies lack the financial incentive to fund the costly trials required for regulatory approval. And without a sponsor, there’s no approval. This means that despite compelling evidence of its benefits, inositol is not an approved treatment for any condition, anywhere in the world.
This book aims to explore two themes. Firstly, the untapped potential of inositol as a therapeutic agent in mental health and other conditions. We will delve into its biological role, the research supporting its use, and how it compares to existing treatments. Secondly, we will also address the systemic barriers—rooted in the economics of modern medicine—that prevent supplements like inositol from gaining the recognition they deserve. I hope that by the end of this book, you will not only understand inositol’s promise but also the broader challenges of bringing safe, effective, and affordable treatments to the forefront of healthcare within the existing approval framework.

"synopsis" may belong to another edition of this title.